Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

CD38-targeted antibody-drug conjugate

DRUG CLASS:

CD38-targeted antibody-drug conjugate

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

Actinium-225 conjugated to daratumumab (2)

Actinium-225 conjugated to daratumumab (2)

›

CD38 expression	Multiple Myeloma	CD38 expression	Multiple Myeloma	STI-6129 Sensitive: D – Preclinical STI-6129 Sensitive : D	STI-6129 Sensitive: D – Preclinical STI-6129 Sensitive : D
CD38 positive	Multiple Myeloma	CD38 positive	Multiple Myeloma	Actinium-225 conjugated to daratumumab Sensitive: D – Preclinical Actinium-225 conjugated to daratumumab Sensitive : D	Actinium-225 conjugated to daratumumab Sensitive: D – Preclinical Actinium-225 conjugated to daratumumab Sensitive : D
CD38 positive	Burkitt Lymphoma	CD38 positive	Burkitt Lymphoma	Actinium-225 conjugated to daratumumab Sensitive: D – Preclinical Actinium-225 conjugated to daratumumab Sensitive : D	Actinium-225 conjugated to daratumumab Sensitive: D – Preclinical Actinium-225 conjugated to daratumumab Sensitive : D